Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.

Detailed Quote for Sanofi (SNYNF)

Detailed Quote for Sanofi (SNYNF)

Sector News | Topic News
News for Sanofi (SNYNF)
Wed, Oct 24, 2018
3:33 PM French Stock Market: Don't Forget The Dividends - SeekingAlpha
Fri, Jun 22, 2018
2:00 AM NICE Recommends Sanofi's New Treatment Dupixent(R) ? (dupilumab) for Adults with Moderate to Severe Atopic Dermatitis in England[1] - PR Newswire
Tue, Jun 05, 2018
2:00 AM New England Journal of Medicine Publishes Cemiplimab Trial Results in Advanced Cutaneous Squamous Cell Carcinoma[1] - PR Newswire
Tue, May 15, 2018
2:00 AM It Affects Over 1.5 Million People in the UK. [1],[2] In a Survey, 80% Report that it Impacts their Mood, Mental Health and Well-Being. But What is Atopic Dermatitis? - PR Newswire
Tue, Apr 10, 2018
1:25 PM 'Safer' Dividend Healthcare Top Gainers Are AbbVie, Sanofi, Lilly, Gilead, & Novartis (All BPh) Per Broker Targets To April 2019 - SeekingAlpha
Thu, Mar 01, 2018
4:59 PM Dividend Gainers: Sanofi, Lilly, Johnson & Johnson, & Gilead Are Tops Per Broker Targets To February 2019 - SeekingAlpha
Sun, Jan 28, 2018
1:13 PM Big Pharma Rules 'Safer' Dividend Healthcare Top Gains Per Broker Targets To January - SeekingAlpha
Mon, Jul 24, 2017
8:32 PM Boulder Growth & Income Fund Is At Least 5% Overvalued And A Poor Long-Term Holding - SeekingAlpha
Fri, Jul 21, 2017
8:07 AM Sanofi Receives CHMP Positive Opinion for Dupixent\u00AE (dupilumab) to Treat Adult Patients with Moderate-to-Severe Atopic Dermatitis - PR Newswire
Tue, Jun 27, 2017
1:47 AM Sanofi Announces Approval of Kevzara\u00AE (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis (RA) in the European Union - PR Newswire
1:45 AM Sanofi Announces Licensing of Kevzara\u00AE (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis (RA) in the European Union - PR Newswire
Wed, Jun 14, 2017
6:30 PM Start Your Morning With a Cup of Coffee and an Ounce of Dengue Prevention - PR Newswire
Tue, Mar 14, 2017
5:29 PM UK Patients Granted Early Access to Sanofi's Innovative Dermatology Treatment Dupilumab by MHRA - PR Newswire
4:30 AM UK Patients Granted Early Access to Sanofi's Innovative Dermatology Treatment Dupilumab by MHRA - PR Newswire
Mon, Feb 27, 2017
2:46 PM Buffett's 2017 Letter To Shareholders - 3 Stocks Close To His Purchase Price - SeekingAlpha
Wed, Feb 08, 2017
3:02 AM Sanofi CEO Interview - FY 2016 Results (video) - PR Newswire
Wed, Feb 01, 2017
2:00 AM Sanofi Appoints Hugo Fry as General Manager UK - PR Newswire
Mon, Dec 12, 2016
12:29 PM Scottish Medicines Consortium Approves Sanofi Prostate Cancer Drug - PR Newswire
Fri, Nov 18, 2016
7:19 AM Global Survey into Perceptions of Men's Health Reveals British Men Are Not Reaping Benefits of Local Health Services and Information - PR Newswire
Fri, Nov 11, 2016
10:00 AM Sanofi Presented Full Results of a PK/PD Study Comparing Toujeo\u00AE to Insulin Degludec in People With Type 1 Diabetes - PR Newswire
More News for SNYNF >>